Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001906324-24-000049
Filing Date
2024-11-08
Accepted
2024-11-07 18:03:52
Documents
85
Period of Report
2024-09-29

Document Format Files

Seq Description Document Type Size
1 10-Q qdel-20240929.htm   iXBRL 10-Q 1354093
2 EX-31.1 ex3119292024.htm EX-31.1 9683
3 EX-31.2 ex3129292024.htm EX-31.2 9794
4 EX-32.1 ex3219292024.htm EX-32.1 5592
  Complete submission text file 0001906324-24-000049.txt   7855734

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20240929.xsd EX-101.SCH 48417
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qdel-20240929_cal.xml EX-101.CAL 93151
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20240929_def.xml EX-101.DEF 216610
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20240929_lab.xml EX-101.LAB 612778
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20240929_pre.xml EX-101.PRE 451716
88 EXTRACTED XBRL INSTANCE DOCUMENT qdel-20240929_htm.xml XML 1337852
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 (858) 552-1100
QuidelOrtho Corp (Filer) CIK: 0001906324 (see all company filings)

EIN.: 874496285 | Fiscal Year End: 0101
Type: 10-Q | Act: 34 | File No.: 001-41409 | Film No.: 241437411
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)